Career

Community Pharmacy Scotland announces first part of funding deal for 2025/2026

Under the funding deal accepted by Community Pharmacy Scotland, in 2025/2026, the guaranteed minimum for reimbursement will increase to £120m.…

Pancreatic exocrine insufficiency: causes, diagnosis and treatment

An overview of the causes, diagnosis and treatments for pancreatic exocrine insufficiency, including a case study of a patient’s experience.…

Hub-and-spoke dispensing expansion set to begin in October 2025

Hub-and-spoke dispensing between different legal entities will be permitted from 1 October 2025 under draft amendments to the Human Medicines Regulations 2012.…

Medicines optimisation teams need to showcase their value to withstand ICB funding cuts

With integrated care boards soon to have lost 65% of their funding over two years, now is the time for medicines optimisation teams to ‘be noisy’ about their work.…

Chief pharmacists call for medicines leadership to be ‘fundamental component’ of strategic commissioning system

In a letter to NHS England, four integrated care board chief pharmacists said that they must shape and lead on medicines at a time of NHS change.…

PJ view: Strengthen the pharmacy frontline to secure the future of NHS healthcare

This month, The Pharmaceutical Journal is launching a dedicated campaign aiming to champion solutions for the pharmacy workforce crisis.…

RPS to launch development programme for prescribing pharmacists

For each of the six themes that will be covered as part of the programme, the Society has said that participants will receive “exclusive learning content, including podcasts, blogs and webinars on essential prescribing topics”.…

Ten ways to implement inclusive recruitment in pharmacy

Tips and advice on how pharmacy teams can promote inclusivity throughout the recruitment process.…

What do recent reviews of research literature tell us about the evolving role of pharmacy and pharmaceutical sciences?

The pick of recent review papers from the RPS chief scientist’s office.…

Regulator ends project on anonymising ethnicity data in fitness-to-practise cases

The General Pharmaceutical Council said unclear evidence on the impact of the scheme meant it could not justify committing further resources to continue it.…